Loading
VV
VBI Vaccines Inc. Stock: price and insider trades · Canada
No insider purchase over the last 90 days. The latest, by GILLIS STEVEN, was filed 23 Sept 2019.
VBI Vaccines Inc.: what insiders have been doing
Every trade that managers of VBI Vaccines Inc. disclose to SEDI is tracked on this page. No insider at VBI Vaccines Inc. has published a filing in the past twelve months. The most recent one dates from 31 July 2023.
Our records for VBI Vaccines Inc. go back to 2016, with 51 purchases and 1 sale on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
119
Thresholds
n/a
Buy Volume
€19M
51 ops. · all time
Sell Volume
€23,061
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 31 July 2023
Declarations119 total
48,333 sharesCommon SharesTSXSEDI:4163356
14,017 sharesCommon SharesTSXSEDI:4162912
259,878 sharesCommon SharesTSXSEDI:4162906
113,583 sharesCommon SharesTSXSEDI:4162910
143,269 sharesCommon SharesTSXSEDI:4162949
18,757 sharesCommon SharesTSXSEDI:4162908
65,927 sharesCommon SharesTSXSEDI:4162890
204,933 sharesCommon SharesTSXSEDI:4162928
587,980 sharesCommon SharesTSXSEDI:4162878
2,925,189 sharesCommon SharesTSXSEDI:4159843
81,602 sharesCommon SharesTSXSEDI:4159841
9,666,667 sharesCommon SharesTSXSEDI:4159847
609,090 shares@ CA$1.6510.8% of flowCommon SharesTSXSEDI:4159851
Canonical exit: 8 Oct 2023 (T+90)
50 shares@ CA$2.4550.5% of flowCommon SharesTSXSEDI:3842597
Canonical exit: 3 Mar 2022 (T+90)
8,150 shares@ CA$2.449280.1% of flowCommon SharesTSXSEDI:3842592
Canonical exit: 3 Mar 2022 (T+90)
Common SharesTSXSEDI:3488123
10,000,000 shares@ CA$0.5060.4% of flowCommon SharesTSXSEDI:3488125
Canonical exit: 18 Dec 2019 (T+90)
40,000 shares@ CA$0.5023.5% of flowCommon SharesTSXSEDI:3435185
Canonical exit: 2 Jan 2020 (T+90)
Common SharesTSXSEDI:3435186
14,500 shares@ CA$0.508.6% of flowCommon SharesTSXSEDI:3435187
Canonical exit: 29 Dec 2019 (T+90)
10,000 shares@ CA$0.482219.4% of flowCommon SharesTSXSEDI:3431064
Canonical exit: 30 Dec 2019 (T+90)
10,000,000 shares@ US$0.50100.0% of flowCommon Shares, no par value per shareSEC:0001012975-19-000612:0
Canonical exit: 18 Dec 2019 (T+90)
8,000 shares@ CA$1.075.9% of flowCommon SharesTSXSEDI:3390417
Canonical exit: 25 Sept 2019 (T+90)
144,000 shares@ CA$0.731520.9% of flowCommon SharesTSXSEDI:3385587
Canonical exit: 17 Sept 2019 (T+90)
8,000 shares@ CA$0.735716.6% of flowCommon SharesTSXSEDI:3385585
Canonical exit: 17 Sept 2019 (T+90)
25 of 119 declarations
About VBI Vaccines Inc.
VBI Vaccines Inc. is a biopharmaceutical company focused on developing vaccines to prevent infectious diseases and cancer. It is listed on the Toronto Stock Exchange under the symbol VBI.
